GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Allurion Technologies Inc (NYSE:ALUR) » Definitions » Beneish M-Score

Allurion Technologies (Allurion Technologies) Beneish M-Score : -5.23 (As of May. 21, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Allurion Technologies Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -5.23 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Allurion Technologies's Beneish M-Score or its related term are showing as below:

ALUR' s Beneish M-Score Range Over the Past 10 Years
Min: -5.23   Med: -5.04   Max: -4.84
Current: -5.23

During the past 3 years, the highest Beneish M-Score of Allurion Technologies was -4.84. The lowest was -5.23. And the median was -5.04.


Allurion Technologies Beneish M-Score Historical Data

The historical data trend for Allurion Technologies's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allurion Technologies Beneish M-Score Chart

Allurion Technologies Annual Data
Trend Dec21 Dec22 Dec23
Beneish M-Score
- - -4.84

Allurion Technologies Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -4.84 -5.23

Competitive Comparison of Allurion Technologies's Beneish M-Score

For the Medical Devices subindustry, Allurion Technologies's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Allurion Technologies's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Allurion Technologies's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Allurion Technologies's Beneish M-Score falls into.



Allurion Technologies Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Allurion Technologies for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.7493+0.528 * 1.0335+0.404 * 0.081+0.892 * 0.744+0.115 * 1.012
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.6875+4.679 * -0.414116-0.327 * 0.6365
=-5.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was $16.16 Mil.
Revenue was 9.386 + 8.235 + 18.2 + 12.96 = $48.78 Mil.
Gross Profit was 6.866 + 6.43 + 13.968 + 9.968 = $37.23 Mil.
Total Current Assets was $53.64 Mil.
Total Assets was $59.99 Mil.
Property, Plant and Equipment(Net PPE) was $5.84 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.87 Mil.
Selling, General, & Admin. Expense(SGA) was $88.24 Mil.
Total Current Liabilities was $66.22 Mil.
Long-Term Debt & Capital Lease Obligation was $2.01 Mil.
Net Income was 5.586 + -19.18 + -21.63 + -21.996 = $-57.22 Mil.
Non Operating Income was 18.983 + 9.967 + 7.144 + -6.172 = $29.92 Mil.
Cash Flow from Operations was -8.636 + -20.871 + -23.094 + -9.699 = $-62.30 Mil.
Total Receivables was $28.99 Mil.
Revenue was 14.071 + 19.184 + 16.064 + 16.25 = $65.57 Mil.
Gross Profit was 11.131 + 15.244 + 12.59 + 12.755 = $51.72 Mil.
Total Current Assets was $45.73 Mil.
Total Assets was $57.97 Mil.
Property, Plant and Equipment(Net PPE) was $6.15 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.93 Mil.
Selling, General, & Admin. Expense(SGA) was $70.29 Mil.
Total Current Liabilities was $83.98 Mil.
Long-Term Debt & Capital Lease Obligation was $19.61 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(16.159 / 48.781) / (28.988 / 65.569)
=0.331256 / 0.442099
=0.7493

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(51.72 / 65.569) / (37.232 / 48.781)
=0.788787 / 0.763248
=1.0335

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (53.639 + 5.839) / 59.988) / (1 - (45.73 + 6.151) / 57.966)
=0.008502 / 0.104975
=0.081

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=48.781 / 65.569
=0.744

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.927 / (0.927 + 6.151)) / (0.868 / (0.868 + 5.839))
=0.130969 / 0.129417
=1.012

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(88.24 / 48.781) / (70.288 / 65.569)
=1.808901 / 1.07197
=1.6875

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((2.011 + 66.221) / 59.988) / ((19.605 + 83.98) / 57.966)
=1.137427 / 1.786996
=0.6365

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-57.22 - 29.922 - -62.3) / 59.988
=-0.414116

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Allurion Technologies has a M-score of -5.23 suggests that the company is unlikely to be a manipulator.


Allurion Technologies Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Allurion Technologies's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Allurion Technologies (Allurion Technologies) Business Description

Traded in Other Exchanges
N/A
Address
11 Huron Drive, Natick, MA, USA, 01760
Website
Allurion Technologies Inc is a leading medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
Executives
Omar Ishrak director 710 MEDTRONIC PKWY, MS LC300, MINNEAPOLIS MN 55432
Nicholas Sheridan Lewin director 3 WEST 57TH ST., 8TH FLOOR, NEW YORK NY 10019
Krishna K. Gupta director, 10 percent owner 307 HARVARD ST, CAMBRIDGE MA 02139
Christopher J Geberth officer: Chief Financial Officer 11 HURON DRIVE, SUITE 200, NATICK MA 01760
Michael R Davin director C/O CYNOSURE, INC., 5 CARLISLE ROAD, WESTFORD MA 01886
Larson Douglas Hudson director 11 HURON DRIVE, SUITE 200, NATICK MA 01760
Benoit Chardon officer: Chief Commercial Officer 11 HURON DRIVE, SUITE 200, NATICK MA 01760
Shantanu Gaur director, officer: Chief Executive Officer 11 HURON DRIVE, SUITE 200, NATICK MA 01760
Ram Chuttani officer: Chief Medical Officer 11 HURON DRIVE, SUITE 200, NATICK MA 01760